Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingApr 2, 2025fentaNYL Citrate PF 200 mcg/100 mLLack of Assurance of SterilityQuVa Pharma, Inc. · D-0296-2025Class IIOngoingApr 2, 2025fentaNYL Citrate PF 200 mcg/100 mLLack of Assurance of SterilityQuVa Pharma, Inc. · D-0295-2025Class IICompletedApr 2, 2025Testosterone Gel 1%Presence of foreign substance: Presence of Benzene.Strides Pharma, Inc. · D-0294-2025Class IICompletedApr 2, 2025Testosterone Gel 1%Presence of foreign substance: Presence of Benzene.Strides Pharma, Inc. · D-0293-2025Class IICompletedApr 2, 2025METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MGPresence of Foreign Tablets/Capsules.A-S Medication Solutions LLC · D-0292-2025Class IIOngoingMar 26, 2025Levothyroxine Sodium TabletsSuper-Potent Drug: Out of specification potency results were obtained.Mylan Institutional, Inc. · D-0291-2025Class IIOngoingMar 26, 2025Levothyroxine Sodium TabletsSuper-Potent Drug: Out of specification potency results were obtained.Mylan Institutional, Inc. · D-0290-2025Class IIOngoingMar 26, 2025CURAD Alcohol Prep PadsSubpotent DrugMEDLINE INDUSTRIES, LP - Northfield · D-0289-2025Class IIOngoingMar 26, 2025Medline Alcohol Prep PadsSubpotent DrugMEDLINE INDUSTRIES, LP - Northfield · D-0288-2025Class IIOngoingMar 26, 2025PRASUGREL TABLETSFailed Dissolution SpecificationsGolden State Medical Supply Inc. · D-0287-2025Class IIOngoingMar 26, 2025NeupogenStability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.Amgen, Inc. · D-0286-2025Class IIOngoingMar 26, 2025NeupogenStability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.Amgen, Inc. · D-0285-2025Class IIOngoingMar 26, 2025CVS Health Concealing Acne Treatment CreamChemical contamination: presence of benzeneFruit Of The Earth, Inc. · D-0284-2025Class IIOngoingMar 26, 2025Walgreens Maximum Strength Tinted Acne Treatment Cream 10% Benzoyl Peroxide/Acne MedicationChemical contamination: presence of benzeneFruit Of The Earth, Inc. · D-0283-2025Class IIOngoingMar 26, 2025Ciprofloxacin Ophthalmic Solution USPDefective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottleFDC Limited · D-0282-2025Class IOngoingMar 26, 2025VitalityMarketed without an approved NDA/ANDA: Product found to be tainted with undeclared sildenafil and tadalafil.One Source Nutrition, Inc, · D-0281-2025Class IIOngoingMar 26, 2025Prasugrel TabletsFailed Dissolution Specifications - low dissolution resultsMylan Pharmaceuticals Inc · D-0280-2025Class IICompletedMar 26, 2025Cinacalcet Hydrochloride Tablets 60 mgCGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.Slate Run Pharmaceuticals · D-0279-2025Class IICompletedMar 26, 2025Cinacalcet Hydrochloride Tablets 30 mgCGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.Slate Run Pharmaceuticals · D-0278-2025Class IIOngoingMar 26, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.Rising Pharma Holding, Inc. · D-0277-2025Class IIOngoingMar 19, 2025Kids by babyganics SPF 50 mineral sunscreen totally tropicalChemical ContaminationJohnson, S C and Son, Inc · D-0276-2025Class IIOngoingMar 19, 2025Kids by babyganics SPF 50 totally tropicalChemical ContaminationJohnson, S C and Son, Inc · D-0275-2025Class IIOngoingMar 19, 2025WalgreensChemical Contamination: Presence of benzeneSigan Industries Group Inc. · D-0274-2025Class IIOngoingMar 19, 2025Zapzyt, Acne Treatment GelChemical Contamination: Presence of benzene.Denison Pharmaceuticals, LLC · D-0273-2025Class IOngoingMar 19, 2025PHENYLephrine added to 0.9% sodium chloridePresence of Particulate MatterCentral Admixture Pharmacy Services, Inc. · D-0272-2025Class IIOngoingMar 19, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.Breckenridge Pharmaceutical, Inc. · D-0271-2025Class IIOngoingMar 19, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.Breckenridge Pharmaceutical, Inc. · D-0270-2025Class IIOngoingMar 19, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.Breckenridge Pharmaceutical, Inc. · D-0269-2025Class IOngoingMar 19, 2025POTASSIUM CHLORIDE InjLabeling: Label Error on Declared Strength. Overwrap labeled as Potassium Chloride Inj 10 mEq may contain flexible containers of Potassium Chloride Inj 20 mEqICU Medical, Inc. · D-0268-2025Class IOngoingMar 19, 2025POTASSIUM CHLORIDE InjLabeling: Label Error on Declared Strength. Cases labeled POTASSIUM CHLORIDE 20 mEq, may contain flexible containers with overwrap mislabeled as 10 mEq. The correct...ICU Medical, Inc. · D-0267-2025Class IIOngoingMar 19, 2025Unisom, SleepMeltsCGMP Deviations: Nitrosamine Drug Substance Related Issue impurity above the daily acceptable intake limit defined by the Food and Drug Administration.Chattem Inc · D-0266-2025Class IIOngoingMar 19, 2025Voriconazole Container Description: voriconazole The product packed in white poly bag containing black poly...CGMP DeviationsAspen Biopharma Labs Pvt., Ltd. · D-0265-2025Class IIOngoingMar 19, 2025LatanoprostCGMP DeviationsAspen Biopharma Labs Pvt., Ltd. · D-0264-2025Class IIOngoingMar 19, 2025Chlorambucil Container Description: The product packed in double self-seal cover and finally packed in...CGMP DeviationsAspen Biopharma Labs Pvt., Ltd. · D-0263-2025Class IIOngoingMar 19, 2025FinasterideCGMP DeviationsAspen Biopharma Labs Pvt., Ltd. · D-0262-2025Class IIOngoingMar 19, 2025Alprostadil Container Description: Amber color bottleCGMP DeviationsAspen Biopharma Labs Pvt., Ltd. · D-0261-2025Class IIOngoingMar 19, 2025BimatoprostCGMP DeviationsAspen Biopharma Labs Pvt., Ltd. · D-0260-2025Class IOngoingMar 19, 2025BD ChloraPrep Clear 1mL ApplicatorsNon-Sterility: contamination of Aspergillus penicillioides, due to breach in package lidding.CareFusion 213, LLC · D-0259-2025Class IIICompletedMar 19, 2025Livalo (pitavatstatin) tabletsPresence of foreign tablets/capsulesKowa Pharmaceuticals America · D-0258-2025Class IITerminatedMar 19, 2025Sodium Chloride Injection 9%Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.Nephron Sterile Compounding Center LLC · D-0257-2025